Krempa David bought ETON

August 24, 2026 · Form 4 insider transaction

Krempa David bought 25,000 shares of Eton Pharmaceuticals, Inc. at $7.31 per share, a transaction worth $182.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.